Dietary n-3 fatty acids and therapy for rheumatoid arthritis (Q40878936)

24 September 2017

1 reference

title

Dietary n-3 fatty acids and therapy for rheumatoid arthritis (English)

1 reference

24 September 2017

0 references

1 reference

M. J. James

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9355207

22 November 2024

L. G. Cleland

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9355207

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9355207

22 November 2024

publication date

1 October 1997

1 reference

24 September 2017

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9355207

full work available at URL

22 November 2024

https://api.elsevier.com/content/article/PII:S0049017297800091?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

https://api.elsevier.com/content/article/PII:S0049017297800091?httpAccept=text/plain

22 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Seminars in Arthritis and Rheumatism

22 November 2024

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

85-97

1 reference

Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

“Homozygosity” for the HLA–DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

1 reference

7 January 2021

The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effects of fish oil supplementation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

EFFECTS OF FISH OIL SUPPLEMENTATION ON NON-STEROIDAL ANTI—INFLAMMATORY DRUG REQUIREMENT IN PATIENTS WITH MILD RHEUMATOID ARTHRITIS—A DOUBLE-BLIND PLACEBO CONTROLLED STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effects of high‐dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs clinical and immune correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Influence of dietary fat on duodenal resistance to acid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Ketoprofen: a preliminary report of its pharmacological activity and therapeutic efficacy in rheumatic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Naproxen: a review of its pharmacological properties and therapeutic efficacy and use.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effects of oral administration of type II collagen on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

A new era for science in nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Omega-3 fatty acids in health and disease and in growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Modification of adjuvant inflammation in rats deficient in essential fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Prostaglandins and leukotrienes as inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Simple relationships exist between dietary linoleate and the n-6 fatty acids of human neutrophils and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Inhibition of human neutrophil leukotriene B4 synthesis in essential fatty acid deficiency: role of leukotriene A hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Effect of dietary supplementation with n-9 eicosatrienoic acid on leukotriene B4 synthesis in rats: a novel approach to inhibition of eicosanoid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Dietary (n-9) eicosatrienoic acid from a cultured fungus inhibits leukotriene B4 synthesis in rats and the effect is modified by dietary linoleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Biochemistry and physiology of n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Separation and quantification of PGE3 following derivatization with pancyl bromide by high pressure liquid chromatography with fluorometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Biological activity of prostaglandin E3 with regard to oedema formation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Interaction between Fish and Vegetable Oils in Relation to Rat Leucocyte Leukotriene Production

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Mediators of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Inhibition of human neutrophil leukotriene B4 synthesis by combination auranofin and eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Australian fish-An excellent source of both arachidonic acid and ω-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Interleukin-1 and its biologically related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

The Victorian Nutrition Survey--intakes and sources of dietary fats and cholesterol in the Victorian population

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980009-1

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

The Long-Term Efficacy and Tolerability of Voltaren (Diclofenac Sodium) And Indomethacin in Rheumatoid Arthritis

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Controlled trial of D(-)penicillamine in severe rheumatoid arthritis

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Diet and Health: Implications for Reducing Chronic Disease Risk

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(97)80009-1

22 November 2024

Identifiers

DOI

1 reference

24 September 2017

1 reference